Vascular Endothelial Growth Factor in a Recipient Cornea Acts as a Prognostic Factor for Corneal Graft Reaction Development

References

• The Collaborative Corneal Transplantation Studies Research Group. The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. Arch Ophthalmol 1992;110:1392–1403
   PubMedGoogle Scholar
• Bachmann B, Taylor RS, Cursiefen C. Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis. Ophthalmology 2010;117:1300–1305
   PubMed Web of Science ®Google Scholar
• Chang JH, Gabison EE, Kato T, Azar DT. Corneal neovascularization. Curr Opin Ophthalmol 2001;12:242–249
   PubMed Web of Science ®Google Scholar
• Cursiefen C, Küchle M, Naumann GO. Angiogenesis in corneal diseases: histopathologic evaluation of 254 human corneal buttons with neovascularization. Cornea 1998;17:611–613
   PubMed Web of Science ®Google Scholar
• Cogan DG. Vascularization of the cornea. Its experimental induction by small lesions and a new theory of its pathogenesis. Trans Am Ophthalmol Soc 1948;46:457–471
   PubMedGoogle Scholar
• Gothard TW, Hardten DR, Lane SS, Doughman DJ, Krachmer JH, Holland EJ. Clinical findings in Brown-McLean syndrome. Am J Ophthalmol 1993;115:729–737
   Google Scholar
• Cursiefen C, Wenkel H, Martus P, Langenbucher A, Nguyen NX, Seitz B. Impact of short-term versus long-term topical steroids on corneal neovascularization after non-high-risk keratoplasty. Graefes Arch Clin Exp Ophthalmol 2001;239:514–521
   PubMed Web of Science ®Google Scholar
• Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4–25
   PubMed Web of Science ®Google Scholar
• Ng EW, Adamis AP. Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration. Can J Ophthalmol 2005;40:352–368
   PubMed Web of Science ®Google Scholar
• Alasil T, Rauser ME. Intravitreal bevacizumab in the treatment of neovascular glaucoma secondary to central retinal vein occlusion: a case report. Cases J 2009;2:176
   Google Scholar
• Lim TH, Bae SH, Cho YJ, Lee JH, Kim HK, Sohn YH. Concentration of vascular endothelial growth factor after intracameral bevacizumab injection in eyes with neovascular glaucoma. Korean J Ophthalmol 2009;23:188–192
   Google Scholar
• Dana R. Comparison of topical interleukin-1 vs tumor necrosis factor-alpha blockade with corticosteroid therapy on murine corneal inflammation, neovascularization, and transplant survival (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc 2007;105:330–343
   PubMedGoogle Scholar
• Wallace GR, John Curnow S, Wloka K, Salmon M, Murray PI. The role of chemokines and their receptors in ocular disease. Prog Retin Eye Res 2004;23:435–448
   PubMed Web of Science ®Google Scholar
• Cursiefen C, Bock F, Horn FK, Kruse FE, Seitz B, Borderie V. GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial. Ophthalmology 2009;116:1630–1637
   PubMed Web of Science ®Google Scholar
• Küchle M, Cursiefen C, Nguyen NX, Langenbucher A, Seitz B, Wenkel H. Risk factors for corneal allograft rejection: intermediate results of a prospective normal-risk keratoplasty study. Graefes Arch Clin Exp Ophthalmol 2002;240:580–584
   PubMed Web of Science ®Google Scholar
• Patel HY, Ormonde S, Brookes NH, Moffatt SL, Sherwin T, Pendergrast DG. The New Zealand National Eye Bank: survival and visual outcome 1 year after penetrating keratoplasty. Cornea 2011;30:760–764
   PubMed Web of Science ®Google Scholar
• Perera C, Jhanji V, Vajpayee RB. Factors influencing outcomes of the treatment of allograft corneal rejection. Am J Ophthalmol 2011;152:358–363
   Google Scholar
• Anshu A, Price MO, Price FW Jr. Risk of corneal transplant rejection significantly reduced with Descemet's membrane endothelial keratoplasty. Ophthalmology 2012;119:536–540
   PubMed Web of Science ®Google Scholar
• Watson SL, Ramsay A, Dart JK, Bunce C, Craig E. Comparison of deep lamellar keratoplasty and penetrating keratoplasty in patients with keratoconus. Ophthalmology 2004;111:1676–1682
   PubMed Web of Science ®Google Scholar
• Maguire MG, Stark WJ, Gottsch JD, Stulting RD, Sugar A, Fink NE. Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group. Ophthalmology 1994;101:1536–1547
   PubMed Web of Science ®Google Scholar
• Dana MR, Streilein JW. Loss and restoration of immune privilege in eyes with corneal neovascularization. Invest Ophthalmol Vis Sci 1996;37:2485–2494
   PubMed Web of Science ®Google Scholar
• Sano Y, Ksander BR, Streilein JW. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction. Invest Ophthalmol Vis Sci 1995;36:2176–2185
   PubMedGoogle Scholar
• Cursiefen C, Schlötzer-Schrehardt U, Küchle M, Sorokin L, Breiteneder-Geleff S, Alitalo K. Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin. Invest Ophthalmol Vis Sci 2002;43:2127–2135
   PubMed Web of Science ®Google Scholar
• Cursiefen C, Chen L, Dana MR, Streilein JW. Corneal lymphangiogenesis: evidence, mechanisms, and implications for corneal transplant immunology. Cornea 2003;22:273–281
   PubMed Web of Science ®Google Scholar
• Liu Y, Hamrah P, Zhang Q, Taylor AW, Dana MR. Draining lymph nodes of corneal transplant hosts exhibit evidence for donor major histocompatibility complex (MHC) class II-positive dendritic cells derived from MHC class II-negative grafts. J Exp Med 2002;195:259–268
   PubMed Web of Science ®Google Scholar
• Kelly TL, Coster DJ, Williams KA. Repeat penetrating corneal transplantation in patients with keratoconus. Ophthalmology 2011;118:1538–1542
   PubMed Web of Science ®Google Scholar
• Shoshani Y, Pe'er J, Doviner V, Frucht-Pery J, Solomon A. Increased expression of inflammatory cytokines and matrix metalloproteinases in pseudophakic corneal edema. Invest Ophthalmol Vis Sci 2005;46:1940–1947
   Google Scholar
• Saghizadeh M, Chwa M, Aoki A, Lin B, Pirouzmanesh A, Brown DJ, et al. Altered expression of growth factors and cytokines in keratoconus, bullous keratopathy and diabetic human corneas. Exp Eye Res 2001;73:179–189
   PubMed Web of Science ®Google Scholar
• Zheng M, Deshpande S, Lee S, Ferrara N, Rouse BT. Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis. J Virol 2001;75:9828–9835
   PubMed Web of Science ®Google Scholar
• Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843–845
   PubMed Web of Science ®Google Scholar
• Bosnar D, Dekaris I, Gabrić N, Markotić A, Lazić R, Spoljarić N. Influence of interleukin-1 alpha and tumor necrosis factor-alpha production on corneal graft survival. Croat Med J 2006;47:59–66
   PubMed Web of Science ®Google Scholar
• Philipp W, Speicher L, Humpel C. Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas. Invest Ophthalmol Vis Sci 2000;41:2514–2522
   PubMed Web of Science ®Google Scholar